targeted-toxins

Zoccal DB, Taxini CL, Gargaglioni LH (2015) Control of sympathetic activity by A5 noradrenergic neurons in the in situ rat preparations. Neuroscience 2015 Abstracts 432.16/X11. Society for Neuroscience, Chicago IL.

Summary: The A5 area represents an important noradrenergic neuronal group located in the ventral pons that receives and sends projections to various medullary areas involved in the cardiorespiratory control. Its involvement in the chemoreflex control was previously studied in anesthetized conditions. In the present study, we explored the contribution of A5 noradrenergic neurons in the processing of sympathetic responses to central and peripheral chemoreceptors stimulation using the in situ working heart-brainstem rat preparation. Juvenile male Holztman rats received bilateral microinjections of either IgG-SAP (50nl, n=7) or toxin anti-dopamine beta-hydroxylase-saporin (anti-DβH-SAP, 4.2 ng/50 nl, n=6) in the A5. One week later, in situ preparations were obtained to record the thoracic sympathetic (tSN) and phrenic nerve (PN) activities; and stimulation of peripheral (KCN, 0.05%, 50nL) and central chemoreceptors (7 and 10% CO2 in the perfusate, 5 min) were performed. Baseline tSN activity (12.5±2.0 vs 12.6±2.4 μV), PN burst amplitude (40.7±9.7 vs 44.8 ±19.9 μV) and frequency (13±1 vs 15±2 bpm) and the respiratory-sympathetic coupling pattern were similar between control and A5-lesioned rats. The sympathetic ([[unable to display character: ∆]]tSN: 110±12 vs 58±8 %, P<0.05), but not the phrenic response to peripheral chemoreflex stimulation was marked attenuated in animals with lesion of A5 noradrenergic neurons. As to the central chemoreflex, the tSN response to 7% CO2 tSN: 9.5±1.4 vs 3.9±1.7%, P<0.05), but not to 10% CO2 (16.4±2.9 vs 10.9±1.6%) was lower in A5-lesioned rats in comparison to controls. On the other hand, the PN response to 7 and 10% CO2 were similar between control and A5-lesioned rats. Our data show that the A5 noradrenergic neurons are critical for the full expression of the sympathetic chemoreflex responses, possibly by providing an excitatory drive to the neurons generating sympathetic activity.

Related Products: Anti-DBH-SAP (Cat. #IT-03), Mouse IgG-SAP (Cat. #IT-18)

Richerson GB, Dragon DN, Jones S, Wu Y, Talman WT (2015) Astrocytic lesions that spare neurons in the nucleus tractus solitarii interfere with cardiorespiratory control. Neuroscience 2015 Abstracts 297.15/B100. Society for Neuroscience, Chicago IL.

Summary: Conjugates of saporin (SAP) have been widely used to target specific neurons while leaving other neurons undisturbed. We found that killing catecholamine neurons bilaterally in the nucleus tractus solitarii (NTS) by injection of the SAP conjugate containing an antibody to dopamine-_-hydroxylase (anti-DBH-SAP) spared non-catecholamine neurons but led to attenuation of baroreceptor reflexes, lability of arterial pressure, and, in some animals, sudden death. In contrast, selective targeting of catecholamine neurons with 6-hydroxydopamine produced no such cardiovascular events. We hypothesized that SAP conjugates may target non-neuronal cells in the NTS. Indeed, we found that local astrocytes were killed by the conjugates as well as by unconjugated SAP itself. SAP injections into the NTS led to death of astrocytes that expressed glial fibrillary acidic protein (GFAP) but did not affect neuronal structural markers and neuronal biosynthetic enzymes. Our recent studies further suggest that local neurons are physiologically intact. Nonetheless, SAP injections into the NTS significantly reduced cardiovascular responses elicited by glutamate agonists injected into the NTS, and bilateral injections of SAP into the NTS led to attenuation of cardiovascular reflexes whose pathways pass through the NTS, lability of arterial pressure, damage to cardiac myocytes and sudden death resulting from asystole. When asystole and death followed SAP treatment the fatal arrhythmia followed progressive bradycardia. In that treated animals demonstrate altered ventilatory function, we conjecture that it is altered ventilation that leads to cardiac compromise and death.

Related Products: Anti-DBH-SAP (Cat. #IT-03)

Holschbach MA, Vitale EM, Lonstein JS (2015) Postpartum lesions targeting serotonergic neurons in the dorsal raphe alter various aspects of maternal behavior. Neuroscience 2015 Abstracts 247.17/R3. Society for Neuroscience, Chicago IL.

Summary: The survival and wellbeing of mothers and their young require high levels of maternal care, aggression toward conspecifics, and low anxiety. These behaviors are affected by pharmacological manipulation of serotonin signaling, but no experiments have analyzed in detail the effects of serotonin-specific lesions of the midbrain on all of these postpartum behaviors. We performed serotonin-specific lesions of the dorsal raphe using a saporin-conjugated toxin targeting the serotonin transporter. After dorsal raphe infusion of the toxin or an inactive control conjugate on postpartum day 2, undisturbed maternal behavior was observed daily and retrieval of scattered pups observed every other day for one week after surgery. Anxiety-like behavior was measured in an elevated plus maze and light dark box on postpartum days 8 and 9, respectively, followed by tests of aggression toward a male intruder in the home cage. Serotonergic lesions of the dorsal raphe altered numerous postpartum behaviors. During undisturbed observations, lesioned animals groomed themselves less and showed more crouching over and less licking of pups. Lesions did not greatly affect pup retrieval or anxiety-like behavior, but did reduce the average duration of attack bouts during aggression testing. This experiment indicates new roles for DR serotonin in the suite of behavioral changes occurring during the postpartum period.

Related Products: Anti-SERT-SAP (Cat. #IT-23)

Ermine C, Wright JL, Parish CL, Thompson LH (2015) Direct impact of dopaminergic and noradrenergic systems on adult-hippocampal neurogenesis in adult rats and the relevance to dementia in Parkinson’s disease. Neuroscience 2015 Abstracts 217.06/C66. Society for Neuroscience, Chicago IL.

Summary: A key pathological feature of Parkinson’s disease (PD) is the progressive degeneration of midbrain dopaminergic neurons, causing motor dysfunction. However there are a range of ‘non-movement’ related features (including cognitive dysfunction, dementia and sleep disorder), which are not alleviated by dopamine replacement therapy. We are currently investigating the hypothesis that reduced hippocampal neurogenesis contributes to cognitive dysfunction in PD. We aim to characterise the effect of the dopaminergic and noradrenergic system on the adult-hippocampal neurogenesis in order to identify potential targets for the treatment cognitive impairments related to neurogenesis. We induced lesions of the different systems in adult rats using stereotaxic injections of toxins: 6-hydroxydopamine (dopaminergic system) and anti-dopa-β-hydroxylase-saporin (noradrenergic system). Four weeks later, the new cells were marked by pulses of bromodeoxyuridine (Brd-U) twice daily for 1 week. The animals were then sacrificed 4 weeks later for tissue collection. A high-performance liquid chromatography has confirmed that both lesions were successful: dopamine level in the striatum dropped to 20% and noradrenaline level in the hippocampus dropped to 8.3%. Surprisingly there was no difference in the number of Brd-U positive cells or in the number of double positive Brd-U/NeuN cells between our groups. The results show that while both noradrenergic and dopaminergic systems are implicated in the onsets of non-motor symptoms, they may not act through the regulation of adult-hippocampal neurogenesis like it was previously thought. Importantly our project has allowed reconsideration of how neurogenesis is involved in PD and redirected the therapies to better potential targets for treatment.

Related Products: Anti-DBH-SAP (Cat. #IT-03)

Yegla B, Francesconi JA, Forde JC, Parikh V (2015) Cholinergic contributions to PASA and functional compensation in rats. Neuroscience 2015 Abstracts 253.11/V29. Society for Neuroscience, Chicago IL.

Summary: Neuroimaging studies have indicated increased recruitment of prefrontal regions coupled to reduced activation of posterior regions in task-performing older adults. This shift of activity in cortical networks is described as posterior-anterior shift in aging (PASA). What cellular mechanisms contribute to PASA and how it provides functional compensation for age-related decline in cognitive capacities remains unknown? Cortically-projecting forebrain cholinergic neurons modulate cortical networks and facilitate attentional processes. Here we examined whether cortical cholinergic inputs contribute to PASA expression and maintenance of attentional capacities in aging. Young (3 months) and aged (24 months) Wistar rats were trained in a sustained attention task (SAT) that requires them to distinguish between signal and non-signal events. After attaining criterion performance (_70% correct responses for 3 consecutive sessions), rats received bilateral infusions of cholinoselective immunotoxin 192-IgG SAP either into the prefrontal cortex (PFC) or posterior parietal cortex (PPC) to produce partial cholinergic deafferentation. Control animals were infused with saline. Following behavioral testing 4 weeks post-surgery, animals were perfused 45-min after the last session to examine changes in neuronal activity in the PFC and PPC using c-fos immunohistochemistry. Partial prefrontal cholinergic deafferentation in aged rats produced robust deficits in response accuracy on signal trials as compared to aged sham (p=0.04) and young lesion (p=0.03) rats. In general, c-fos expressing neurons were higher in the PFC of aged rats as compared to young rats. Although prefrontal neuronal activity did not differ between the aged sham and PFC lesion group, there was a trend for a higher neuronal activity in the PPC of the latter. Surprisingly, attentional performance displayed a negative correlation with the prefrontal activity. Neuronal activity in the PPC did not correlate with performance. PPC-infused aged rats displayed no lesion effect on SAT and performed better than aged rats infused with 192 IgG-SAP into the PFC (p=0.04). Moreover, partial loss of cholinergic inputs into the PPC reduced PFC recruitment as compared to PFC lesioned aged rats. Collectively, these data suggest that reduced cortical activity in young rats compared to aged rats may represent better neural capacity, or the efficient utilization of normal brain regions, for task performance. Moreover, PASA is not triggered by prefrontal cholinergic inputs, but these inputs may regulate the reciprocal interactions between the PFC and PPC networks to maintain optimal performance in aging.

Related Products: 192-IgG-SAP (Cat. #IT-01)

Nair DV, Al-Badri MM, Peng H, Pachego-Quinto J, Eckman CB, Iacono D, Eckman EA (2015) Preliminary investigation on the antidepressive effect of chronic oxotremorine treatment in a rodent model of Alzheimer’s disease. Neuroscience 2015 Abstracts 40.29/C34. Society for Neuroscience, Chicago IL.

Summary: Alzheimer’s disease (AD) is a progressive neurodegenerative disease and the rate of progression varies from individual to individual. A great deal of evidence supports the idea that depression and other neuropsychiatric conditions co-exist with cognitive decline. However, the neurobiological basis of these symptoms and their influence on the clinical course of AD remain unclear. Our lab has shown previously that the 192-IgG saporin rat model of AD-like basal forebrain cholinergic cell loss exhibits a depression-like phenotype that develops months after the well-described impairment in spatial working memory. Furthermore, we have shown that chronic intracerebroventricular administration of the muscarinic agonist oxotremorine reverses both spatial working memory deficits and the depression-like behavior triggered by cholinergic denervation, and induces hippocampal neurogenesis. Current experiments are focused on determining additional pathological correlates of depression in this model and how they may be modulated by muscarinic agonists. To induce AD-like basal forebrain cholinergic cell loss, adult female Sprague Dawley rats were injected intracerebroventricularly (icv) with the immunotoxin 192-IgG-saporin (SAP) or saline as control (SHAM). After a 5 week recovery period, the rats received either 2 or 6 weeks of icv infusion of either oxotremorine or vehicle (saline) via osmotic minipump. Behavioral testing to assess the depressive phenotype was carried out using the sucrose consumption test every 2 weeks during oxotremorine treatment. The phenotype was further confirmed by forced swim test. The levels of ChAT, tryptophan hydroxylase (TPH), muscarinic receptors and FosB and ΔFosB were assessed in the hippocampus, basal forebrain, and orbitofrontal cortex by western blot and immunohistochemistry. Our preliminary results show increases in TPH, M1 receptors and FosB in the hippocampus, basal forebrain, and orbitofrontal cortex of a subset of treated animals, but no changes ChAT or ΔFosB. Further experiments are in progress to determine if there are changes in the expression of these and additional proteins in other brain regions including the nucleus accumbens, an area involved in activational aspects of motivation which also contributes to behavioral disorders such as to depression. The results of these studies may provide new insight in understanding the molecular basis of depression and antidepressant action of oxotremorine thereby defining new targets for possible therapeutic intervention for depressive symptoms in AD.

Related Products: 192-IgG-SAP (Cat. #IT-01)

Pittenger CJ (2015) Modeling Tourette syndrome pathophysiology through targeted manipulation of striatal interneurons. Neuroscience 2015 Abstracts 6.07. Society for Neuroscience, Chicago IL.

Summary: Postmortem studies of Tourette syndrome patients has revealed a reduction in the number of specific striatal interneurons. The authors explored the hypothesis that this neuronal deficit is enough to produce the symptoms of Tourette syndrome in mice. Animals received 90-ng injections of Anti-ChAT-SAP (Cat. #IT-42) into the striatum. Rabbit IgG-SAP (Cat. #IT-35) was used as a control. The data suggest that loss of the striatal interneurons is enough to produce some, but not all, of the symptoms caused by Tourette syndrome.

Related Products: Anti-ChAT-SAP (Cat. #IT-42), Rabbit IgG-SAP (Cat. #IT-35)

See Also:

• Xu M et al. Targeted ablation of cholinergic interneurons in the dorsolateral striatum produces behavioral manifestations of Tourette syndrome. Proc Natl Acad Sci U S A 112:893-898, 2015.

Q: I’m trying to find out if enough Anti-DBH-SAP will be retrogradely transported and taken up by non targeted sympathetic neurons by bulk fluid-phase endocytosis. Does saporin become degraded after it kills the neuron or does it enter the extracellular matrix?

A: It is very unlikely that a targeted toxin such as Anti-DBH-SAP is freed from the targeted neuron in a meaningful condition. There has never been a reported identification of a targeted toxin, functionally or not, after it has eliminated its targeted neuron. Current evidence indicates that effective suicide transport agents undergo endocytosis at nerve terminals followed by retrograde axonal transport of the endocytic vesicles containing the toxin. Experiments using vincristine have shown that the retrograde axonal transport of suicide transport toxins utilizes the fast transport system (microtubules). However, it is not known what determines whether or not a specific toxin-ligand undergoes axonal transport after internalization.

Related Products: Anti-DBH-SAP (Cat. #IT-03)

Aoki S, Wickens JR (2015) Featured Article: A specific immunotoxin elucidates a causal role of striatal cholinergic system in behavioral flexibility. Targeting Trends 16(4)

Related Products: Anti-ChAT-SAP (Cat. #IT-42)

Read the featured article in Targeting Trends.

See Also:

• Aoki S et al. Role of Striatal Cholinergic Interneurons in Set-Shifting in the Rat. J Neurosci 35:9424-9431, 2015.

Aicher S, Hermes S, Hegarty D (2015) Denervation of the lacrimal gland leads to corneal hypoalgesia in a novel rat model of aqueous dry eye disease. Invest Ophthalmol Vis Sci 56:6981-6989. doi: 10.1167/iovs.15-17497

Summary: One result of functional disruption of the tear gland is dry eye disease (DED), which represents a group of disorders rather than a singular one. DED manifests itself in altered responses to noxious corneal stimulation, but many of these patients do not actually have dry eyes or tear gland dysfunction. In order to investigate what circuits are involved in DED the authors created two models, one of which used the ablation of p75 receptor-expressing neurons innervating the extraorbital lacrimal gland. Rats received 2.5 μg of 192-IgG-SAP (Cat. #IT-01) directly into the left extraorbital lacrimal gland. Tear production in the lesioned animals was normal, and responses to noxious cold stimuli were impaired. This accompanied by unchanged fiber density indicates that the nociceptive signaling was affected on a molecular level.

Related Products: 192-IgG-SAP (Cat. #IT-01)